Timo Minssen
Professor
JUR Center for Advanced Studies in Bioscience Innovation Law
Karen Blixens Plads 16
2300 København S
215. Recent Advances in Medical Device Regulation. Guests, Timo Minssen, Helen Yu, Janos Meszaros, Christopher Robertson, and Preeti Mehrotra.
14/08/2020
1 Media contribution
Press/Media: Press / Media
Artificiell intelligens– löftesrik teknik med etiska utmaningar
02/06/2019
1 Media contribution
Press/Media: Press / Media
As doações de voz podem ajudar investigadores a aprender mais sobre a covid-19. É a falta de dados que dificulta há anos avanços no diagnóstico de várias doenças físicas e mentais através da voz
06/12/2020
1 Media contribution
Press/Media: Press / Media
At NY Genome Center, Legal Expert Presents Ethical Dilemmas in Gene Editing
29/08/2019
1 item of Media coverage
Press/Media: Press / Media
Comments on FDA Action Plan for Oversight of Artificial Intelligence/Machine Learning-Based Medical Software
01/01/2021
1 Media contribution
Press/Media: Press / Media
Commission’s new strategy aims to rewrite pharma rules
01/12/2020
1 Media contribution
Press/Media: Press / Media
Danmark overdrog sin vaccineproduktion til saudiarabisk firma – det kan koste danskernes helbred dyrt
17/05/2020
1 Media contribution
Press/Media: Press / Media
EU beskytter vaccine-producenter mod dyre erstatningssager
12/11/2020
1 Media contribution
Press/Media: Press / Media
Eksperter: Befolkningslaboratorium med rod i andelstanken kan eliminere de blinde pletter i sundhedsforskningen
Carsten Obel, Trine Rolighed Thomsen, Frederik Mølgaard Thayssen, Lars Münter, Kasper Karmark Iversen, Timo Minssen & Kaj Grønbæk
26/05/2021
1 Media contribution
Press/Media: Press / Media
En NY Genome Center, un experto legal presenta dilemas éticos en la edición de genes
29/08/2019
1 item of Media coverage
Press/Media: Press / Media
En klodset administrativ revolution
Timo Minssen & Ryan Long
01/06/2018
1 Media contribution
Press/Media: Press / Media
European Unified Patent Court plans for life after Brexit
19/03/2020
1 Media contribution
Press/Media: Press / Media
Flere firmaers patenter er i farezonen efter omstridt EU-dom: Selskaber, der har fået patent på forskning med visse stamceller, risikerer at komme til at stå med et ugyldigt patent i hånden
22/03/2012
1 Media contribution
Press/Media: Press / Media
GMO Regulations in Europe Are “Not Fit for Purpose”
11/11/2020
1 Media contribution
Press/Media: Press / Media
GSK's selvmordssag kan sætte gang i medicinspekulanter
17/05/2017
1 Media contribution
Press/Media: Press / Media
Gennemsigtighed i menneskeforsøg kan standse udvikling af ny medicin
30/06/2016
1 Media contribution
Press/Media: Press / Media
Genpatent avvisas av EUs patentverk: Europeiska patentmyndigheten, EPO, godkänner inte amerikanska Myriad Genetics patentansökan för diagnos av bröstcancergenen BRCA1.Men segern är ännu inte vunnen
01/06/2004
1 Media contribution
Press/Media: Press / Media
German court blocks approval of European patent system
20/03/2020
1 Media contribution
Press/Media: Press / Media
In Conversation With... Sara Gerke and Timo Minssen
23/06/2020
1 Media contribution
Press/Media: Press / Media
Influencer Dies After Drinking Pesticide During Livestream As Viewers Encouraged Her Suicide
Karen Celedonia, Marcelo Corrales Compagnucci, Michael Lowery Wilson & Timo Minssen
18/10/2021
1 item of Media coverage
Press/Media: Press / Media
Interview for WHO: Regulating digital health
01/04/2020
1 Media contribution
Press/Media: Press / Media
Interview on the Role of Patents and Licensing in the Governance of Human Genome Editing
01/06/2021
1 Media contribution
Press/Media: Press / Media
ID: 16150437
Most downloads
-
4325
downloads
När anses en bioteknologisk uppfinning vara komplett och praktiskt användbar? – Del 1: – Om nyare utvecklingar kring kravet på ’industrial application’ och ’utility’ för gen- och proteinrelaterade uppfinningar i USA och Europa
Research output: Contribution to journal › Journal article › peer-review
Published -
2171
downloads
The Evolution of the CJEU’s Case Law on Stem Cell Patents: Context, Outcome and Implications of Case C‑364/13 International Stem Cell Corporation.
Research output: Contribution to journal › Journal article › peer-review
Published -
2073
downloads
När anses en bioteknologisk uppfinning vara komplett och praktiskt användbar? – Del 2: Om nyare utvecklingar kring kravet på ’industrial application’ och ’utility’ för gen- och proteinrelaterade uppfinningar i USA och Europa
Research output: Contribution to journal › Journal article › peer-review
Published